Status:
RECRUITING
Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis
Lead Sponsor:
Tata Memorial Centre
Collaborating Sponsors:
Indian Statistical Institute, Kolkata
Conditions:
Glioma
Eligibility:
All Genders
1+ years
Brief Summary
Glioma are type of primary brain tumors arising within the substance of brain. Different type of gliomas are seen which are classified depending upon pathological examination and advanced molecular te...
Detailed Description
In the proposed retrospective study, images (MRI, CT, or PET) undertaken as part of standard of care (pre-treatment, post-operative, response assessment, and surveillance) will be analyzed. The DMG da...
Eligibility Criteria
Inclusion
- Patients with glioma or glioma-mimicking pathology with imaging available in TMC between January 2010 and December 2022.
Exclusion
- Imaging done outside TMC.
- Motion artifacts or other artifacts causing image degradation.
- Size of tumor or region of interest \< 1 cm in the largest dimension
Key Trial Info
Start Date :
February 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06036381
Start Date
February 15 2024
End Date
December 1 2026
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012